Roopa Industries Limited (BOM:530991)

Market Cap	405.31M -4.6%
Revenue (ttm)	1.28B +11.9%
Net Income	19.34M -6.6%
EPS	2.46 -6.5%
Shares Out	7.87M
PE Ratio	20.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	556
Open	54.51
Previous Close	53.98
Day's Range	50.06 - 54.51
52-Week Range	38.10 - 71.99
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About Roopa Industries

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenyl phosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India.

• Industry: Chemicals and Allied Products
• Founded: 1985
• Employees: 51
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530991

Financial Performance

In fiscal year 2025, Roopa Industries's revenue was 1.23 billion, an increase of 72.14% compared to the previous year's 713.87 million. Earnings were 20.35 million, an increase of 33.95%.